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ChIP-Seq Data Analysis to Define
Transcriptional Regulatory Networks
Giulio Pavesi
Abstract The first step in the definition of transcriptional regulatory networks is to
establish correct relationships between transcription factors (TFs) and their target
genes, together with the effect of their regulatory activity (activator or repressor).
Fundamental advances in this direction have been made possible by the introduc-
tion of experimental techniques such as Chromatin Immunoprecipitation, which,
coupled with next-generation sequencing technologies (ChIP-Seq), permit the
genome-wide identification of TF binding sites. This chapter provides a survey
on how data of this kind are to be processed and integrated with expression and
other types of data to infer transcriptional regulatory rules and codes.
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1 Introduction: Chromatin Immunoprecipitation
and Next-Generation Sequencing
The introduction of next-generation sequencing (NGS) technologies has opened up
new avenues for every type of genetic and genomic research [1, 2]. One of the fields
in which the impact of NGS has been more relevant is perhaps the study of gene
regulation at the transcriptional level, and the subsequent analysis steps such as the
construction of regulatory networks.
It is essential for the definition of transcription regulatory networks to establish
correct relationships between regulators such as transcription factors (TFs) and the
genes they regulate [3], together with the effect of the activity of the TFs (activator
or repressor) [4]. A fundamental step forward in this direction has been made
possible by lab techniques enabling the large-scale identification of TF-DNA
binding sites on the genome, with experiments simply impossible to perform just
a few years ago.
Chromatin is a complex of DNA and proteins that forms chromosomes within
the nucleus of eukaryotic cells. Chromatin Immunoprecipitation (ChIP) [5] is a
technique enabling the extraction from the cell nucleus of a specific protein-DNA
chromatin complex, including DNA binding proteins such as TFs. The different
steps of a ChIP experiment are summarized in Fig. 1. First of all, the DNA-bound
proteins are cross-linked, that is, fixed to the DNA. The cross-linked chromatin is
usually sheared by sonication, providing fragments of 300–1,000 base pairs (bps) in
length. Then a specific antibody that recognizes only the protein (TF) of interest is
employed, and the antibody, bound to the TF which in turn is bound to the DNA,
permits the selective extraction and isolation of the chromatin complex. At this
point, DNA is released from the TF by reverse-crosslinking and purified, and the
result is a DNA sample enriched in regions corresponding to the genomic locations
of the sites that were bound in vivo by the TF (or, in general, the DNA-binding
protein) studied. The experiment is performed on thousands of cells at the same
time so as to have a quantity of DNA suitable for further analysis and to have
enough “enrichment” in the sample, that is, enough copies of each of the DNA
regions bound by the TF, to discriminate them from experimental noise.
The next phase is quite logically the identification of the DNA regions them-
selves – and of their corresponding location in the genome. The introduction of
“tiling arrays” had permitted for the first time the analysis of the DNA extracted on
a whole-genome scale (ChIP on Chip [4, 6]) by using probes designed to cover the
sequence of a whole genome, or a subset of genomic regions of interest (such as
with promoter arrays). The introduction of NGS technologies has enabled this type
of experiment to move one step further by providing at reasonable cost perhaps the
simplest solution: to identify the DNA extracted by the cell by immunoprecipita-
tion, sequence the DNA itself (ChIP Sequencing, or ChIP-Seq [5, 7]).
Without delving into technical details, given a double-stranded DNA fragment
derived as just described, sequencing determines the nucleotide sequence on either
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end sequencing). For technical limitations, current NGS platforms can determine
the sequence of only a fragment of each region, usually ranging from 50 to 150 bps.
Thus, the output is a huge collection of millions of short sequences (called reads),
which mark the beginning of either or both strands of a DNA region of the sample.
The overall number of sequence reads obtained varies from experiment to exper-
iment, and depends on several factors such as the TF involved, sample preparation,
experiment replicates, and so on. Suffice it to say that it usually ranges from a few to
dozens of millions of short sequence reads.
Once the sequencing has been completed, computational analysis of the data
determines which were the DNA regions enriched in the sample (see Fig. 2). First of
all, the reads are aligned or “mapped” on the genome to determine their original
Fig. 2 Schematic view of the result of a ChIP-Seq experiment on a genomic region bound by a
TF. DNA is fragmented at random by sonication, and thus the ends of sequenced DNA fragments
map on different positions on the genome. Each fragment is assumed to be the 50 of a 200–300 bps
region, and therefore extended. The resulting signal plot (“coverage”) shows a typical “peak”
shape. The actual DNA sequence bound by the TF should be located in correspondence of the point
of maximum of the coverage plot (bottom)
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position, using one of the several tools available for this task [8]. It is common, at
this stage, to have mismatches in the alignment, that is, sequence reads differ from
the reference genome sequence usually in single nucleotides. This is for both
biological (sequence polymorphisms) and technical (sequencing errors) reasons.
Thus, alignment is usually performed allowing for two or three substitutions per
read, with no insertions or deletions. In addition, a non-negligible number of
sequence reads align at multiple positions, that is, correspond to repetitive regions
of the genome. Although originally these were discarded from further processing, it
has indeed been shown that TFs can bind repetitive elements of the genome
[9]. Thus, reads mapping at multiple positions should also be considered in the
remainder of the analysis, for example also keeping those that map at most in ten
different positions.
Once read mapping is complete, regions bordered by reads on both ends
(on opposite strands) in numbers high enough to represent a “significant enrich-
ment” and not sample contamination or random noise are singled out. This latter
step should be performed with respect to a “control” experiment, aimed at produc-
ing “random DNA” and thus a random background model. In other words, if
“random” genomic DNA was included in immunoprecipitated samples, another
experiment producing only “random” DNA from the same type of cell should give
the opportunity to filter the results from false positives and artifacts. The control
experiment can be performed in different ways by using an antibody not specific for
any TF or, if possible, by using a cell in which the gene encoding the TF studied has
been “knocked out,” or its expression “knocked down” in order to remove the
immunoprecipitated protein from cells [10].
An ideal example of enriched region is shown in Fig. 2. A “true positive” should
correspond to a genomic region bordered by several reads on both strands, and the
reads on the two ends should be at a distance “typical” of experiments of this kind,
that is, a few hundred bps. By plotting the number of reads falling in each genomic
position, the region should be comprised between two “peaks,” one made by reads
on the positive strand and one on the negative. Each read mapped on the genome
can also be extended by the estimated length of the immunoprecipitated DNA
fragments. The latter, following a size-selection step before sequencing, is usually
about 200 bps. The result is a signal plot estimating how many times each nucle-
otide of the genome is covered by an “extended read.” Then a “significantly
enriched” region should correspond to a peak in the signal plot, usually located in
the middle of the region itself. As in experiments such as ChIP-Seq enrichment is
essential to obtain reliable results, single-end sequencing is preferred over paired-
end, which would produce at the same cost exactly one half of the sequences, and
thus less enrichment.
On the other hand, the same region should not appear – at least with the same
number of bordering reads or with the same height of the central peak – in the
control experiment. Given the shape of the enriched regions as shown in Fig. 2, this
part of the analysis is usually referred to as “peak calling,” that is, identifying all the
“peak shaped” regions whose enrichment can be considered to be statistically
significant. From the introduction of ChIP-Seq experiments, several different
ChIP-Seq Data Analysis to Define Transcriptional Regulatory Networks
methods for peak calling have been introduced, all following the above consider-
ations but differing in the statistical approaches employed in the definition of
significant enrichment. The latter is computed according to the overall number of
reads that can be associated with a candidate peak, their distribution on the two
DNA strands, and the height of the peak summit. These values are in turn compared
to background expected values that might or might not be derived from a control
experiment. In a quite ample literature, a few methods have emerged over the years
as de facto standards, such as, for example, MACS [11, 12], SPP [13], and PeakSeq
[14], which have been employed in the large scale analysis of hundreds of ChIP-Seq
experiments performed in the framework of the ENCODE project [15, 16].
The output of peak-calling is a list of genomic regions, likely to be bound by the
TF studied in vivo, with p-values and false discovery rates (FDRs) associated with
each one. Thus, not only is a “yes/no” output provided but also an estimate of the
probability of each region to be considered a false positive call, and hence an
estimate of its actual enrichment in the sample. The latter can be employed to
restrict, for example, downstream analyses only to the “most likely” or “most
significantly enriched” candidates (e.g., only those for which the estimated FDR
is under a given threshold). In addition, the “summit” point of each region is usually
included in the output, that is, the genomic coordinate of the single base pair where
the signal plot associated with the peak is maximum (see Fig. 2). As the actual point
of contact with DNA of the TF or the complex investigated should be present in all
the regions extracted, the latter should be close to the summit point, which can thus
be used to approximate the binding site of the TF within the region for downstream
analyses.
2 Finding Transcription Factor Binding Sites
The actual DNA region bound by a TF usually ranges in size from 8–10 to 16–20
bps [3]. TFs bind the DNA in a sequence-specific fashion, that is, they recognize
sequences that are similar but not identical, differing in a few nucleotides from one
another. As peak regions bound by a TF identified through ChIP-Seq are usually
several hundreds of bps long, further processing is needed to identify the actual
binding sites within them. Motif discovery or enrichment tools can be employed for
this task [17, 18]. The general idea is that the regions identified by the ChIP-Seq,
should contain a subset of oligos appearing in all or most of the sequences (thus
allowing for experimental errors and the presence of false positives in the set)
similar enough to one another to be instances of sites recognized by the same
TF. The same set of similar oligos should also not appear with the same frequency
and/or the same degree of similarity in a set of sequences selected at random or built
at random with a generator of “biologically feasible” DNA sequences [19]. This set
of similar and over-represented oligos collectively build a motif recurring in the
input sequences, describing the binding specificity of the TF itself. Instances of the
motif within the enriched regions can then be used to identify the actual binding
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sites within them. A motif enrichment analysis might also be useful for the
identification of additional motifs enriched within the regions which could corre-
spond to binding sites for additional TFs binding DNA in close proximity to the one
investigated [20], and thus likely to co-associate with it forming regulatory
modules.
3 Associating Binding Sites with Target Genes
The results of ChIP-Seq experiments provide a map of the binding sites on the
genome for the TF investigated, but obviously no information regarding genes
whose transcription is affected by each of the binding sites. For building regulatory
networks it is therefore essential to associate each region with one or more “target”
genes.
The first logical step is to single out binding sites located within promoters.
There is no unique definition of what constitutes the “promoter” of a gene or of its
size. It is usually described as a region of a few hundred or thousand base pairs
located upstream of its transcription start site (TSS). ChIP-Seq experiments
performed on histone modifications, however, revealed that active promoters
have a very precise chromatin signature, that is, a pattern of modifications such
as H3K4me3 or H3K9ac covering a few nucleosomes upstream and downstream of
the TSS itself [21]. Hence, even if it narrows down the number of binding sites that
can be assigned to promoters, it is advisable not to define a region too broad around
TSSs as “promoter” and avoid going beyond 1 kbp upstream or downstream of the
TSS. Indeed, TF binding regions outside these “core promoters” (e.g., within the
first intron or further than 1 kbp upstream of the TSS) exhibit a different chromatin
signature, with modifications such as H3K27ac or H3K4me1 that are indicators of
distal “enhancer” or “silencer” regions but not of promoters.
Associating distal binding sites, not close to TSSs, with the “right” target genes
is perhaps the hardest part of this type of analysis. Even factors usually associated
with promoters and TSSs such as NF-Y [9, 22] have the majority of their binding
sites located in distal regulatory regions. Thus, restricting the analysis only to
binding sites located in promoters has the effect of missing several target genes
regulated by the binding of the TF to distal elements; on the other hand, associating
a distal regulatory element with the wrong gene produces wrong data.
In the absence of further information, this step usually follows the “nearest
neighbor rule”: a distal binding site is associated with the closest TSS on the
genome. If the binding site is within a gene body (the transcribed region of a
gene) then it is attributed to the gene itself. Given a reference annotation providing
the genomic coordinates of genes that can be retrieved from any genome browser
[23, 24], this analysis can be performed with in-house developed scripts, or with
tools such as HOMER [25] or GREAT [26]. On the other hand, as a typical ChIP-
Seq experiment returns several thousands of bound regions, associating every peak
with the closest TSS results in a very sizable portion of the annotated genes to be
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considered targets of the TF investigated. Hence, further criteria are employed to
reduce their number, usually by establishing a threshold on the distance from the
TSS of the binding sites. For example, in the large-scale analysis performed in the
Roadmap Epigenomics project [21], an enhancer region was associated with the
closest gene if its TSS was located at less than 30 kbp from the enhancer itself.
Otherwise, no association was defined.
Modern experimental techniques based on immunoprecipitation and NGS, the
most relevant being ChIA-PET or ChIA-Seq experiments [27, 28], have enabled
light to be shed on this aspect too. The ChIA-PET (or -Seq) method combines ChIP-
Seq methods and Chromosome conformation capture techniques such as 3C [29]
for the identification of long-range chromatin regulatory interactions [30]. The
immunoprecipitation is performed against a protein usually found in complexes
connecting enhancers to the respective TSSs, such as p300, to be pulled down
together with all the DNA regions bound to it. Before sequencing, linker sequences
are incorporated onto the free ends of the DNA fragments tethered to the protein
complexes. To build connectivity of the DNA fragments, the linker sequences are
ligated by nuclear proximity ligation. The resulting DNA sequences is thus formed
by both the enhancer and the promoter, connected by a linker sequence. Application
of NGS paired-end sequencing produces sequence pairs coming from each of the
two connected regions. Subsequent mapping on the genome finally results not in
single peaks but in “paired” peaks, located at different positions of the genome,
where reads in one peak are found to be paired in sequencing with reads in the other.
Paired peaks correspond to pairs of genomic regions connected by the protein
complex immunoprecipitated. These experiments thus enable the identification of
unique, functional chromatin interactions between distal and proximal regulatory
transcription-factor binding sites and the promoters of the genes with which they
interact. Remarkably, their application has revealed the serious limitations of the
application of the “nearest neighbor” rule introduced before: for example, in mouse
stem cells only about one-third of the long-distance enhancer-promoter interactions
have been shown to be associated with the gene nearest to the enhancer [31]. An
enhancer located within a transcribed region can also regulate a distal gene. Finally,
a sizable number of the enhancers (about 30% of the total) were even associated
with genes located on different chromosomes. All in all, then, in the absence of
long-distance interaction data, all the enhancer-promoter associations should be
taken with a pinch of salt.
4 Assessing TF Activity from Expression Data
TFs can have the effect of both activating and repressing the transcription of target
genes. Thus, the activity of any TF can be assessed by performing experiments in
which the expression of the TF is limited or, vice versa, amplified. Then the activity
of the TF on target genes can be measured by identifying those genes that change
their expression level as a consequence of the TF inactivation or over-expression.
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Before the introduction of genome-wide techniques such as ChIP-Seq this was
indeed the method of choice for the identification of putative target genes for TFs. It
is, however, important to stress the fact that this approach, alone, might also
identify genes that are not direct targets. In other words, the TF directly affects
the expression of a subset of differentially expressed genes; some of the direct
targets can in turn regulate further genes, also found to be differentially expressed,
and so on.
Before the advent of NGS technologies, expression studies were usually
performed with oligonucleotide microarrays. Then the application of NGS to
RNA (RNA-Seq) was shown to be able not only to reconstruct and assemble
whole transcriptomes, but also to provide a reliable quantification of the expression
level of each gene [32, 33].
One of the key advantages of RNA-Seq over microarrays is that they enable one
to identify and reconstruct the single alternative transcripts of the same gene, as
well as estimate their expression level. This, in turn, has revealed alternative
splicing and alternative transcript production to be ubiquitous features of eukaryotic
genes [34]. From the viewpoint of transcription regulation it is worth mentioning
that alternative promoters and transcription start sites have emerged as a wide-
spread feature. This is a very important point in the association between TF binding
and promoters, as a TF-gene association could be missed if the alternative promoter
bound by the TF is not included in the analysis. For a TF binding only one of the
alternative promoters of a gene, its effect on gene transcription should be assessed
only for the corresponding transcripts. Techniques such as Cap Analysis Gene
Expression (CAGE [35]), coupled with NGS sequencing [36], enable one to
identify more reliably alternative TSSs and the relative transcription level.
It is worth mentioning that the usual measures of transcript level employed are
concentration measures. That is, the “expression level” of a transcript or gene is an
estimate of the fraction of the RNA sample that can be assigned to it, described by
normalized measures such as “reads per kilobase of exon per million reads”
(RPKM) or “transcripts per million” (TPM). This, in turn, can produce incorrect
conclusions when applied to experiments resulting from TF inactivation or over-
expression. Suppose, for example, that a TF acts purely as an activator, targeting
10% of the genes of the genome studied. Upon inactivation of the TF, the transcript
level of its target genes is decreased and the rest of the genome remains unchanged.
As expression measures used are relative and describe concentration with respect to
the overall sample, we observe a marked reduction of the transcript levels for the
target genes, but at the same time an increase of the expression estimate of
non-target genes, some of which might also finally be “significantly over-
expressed” by statistical analysis. Hence, the TF is incorrectly observed to act
both as an activator and a repressor. Other than previous knowledge about the TF
activity, indicators of the possible presence of this effect for an activator TF are a
large majority of genes significantly down-regulated with just a few over-
expressed, the latter having very high expression estimates. Vice versa for repressor
TFs. In case of doubt, special techniques should be employed in the design and
analysis of the expression experiment, as shown, for example, in [37].
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5 Mining Available Data
The ever decreasing cost of next-generation sequencing has led to the widespread
application of the techniques described in this chapter, such as ChIP- and RNA-Seq.
It has indeed become common practice to study simultaneously more than one TF
in a given condition in order to have more meaningful results and to identify
co-associations and modules of key regulators [38, 39]. The last few years have
also witnessed the completion of large-scale general purpose projects in which
hundreds of TFs have been tested in several different cell lines. The most relevant
example is perhaps the (still ongoing) ENCODE project [40], in which hundreds of
human and mouse TFs have been analyzed through ChIP-Seq in several different
cell lines, or the modENCODE project for model organisms such as Drosophila
melanogaster or Caenorhabditis elegans [41]. TF ChIP-Seq data are integrated by
other data relevant for transcriptional regulation analysis such as chromatin struc-
ture, histone modifications, DNA methylation, expression profiles from RNA-Seq
and CAGE experiments, and ChIA-PET data for long-distance chromosomal inter-
actions. Analysis of co-occurrence of TF binding sites of the genome revealed that
TFs tend to associate, forming distinct co-regulatory modules [15], giving rise to
many enriched regulatory network motifs (e.g., noise-buffering feed-forward
loops). Hence, any TF should not be viewed as a separate entity whose interactions
with other regulatory factors happen only by chance, but should be considered as
part of more complex regulatory modules, and the construction of regulatory
networks should consider this point.
Other than the deluge of information they contain, these data, or those contained
in large repositories such as Cistrome [42], constitute a perfect benchmark set for
any bioinformatics or systems biology approach to the study of transcriptional
regulation. They can also be retrieved to complement data produced locally.
There also exist resources in which data have already been processed, for example
tools such as Cscan [43] or Enrichr [44], which already have pre-computed asso-
ciations between TFs and target genes for hundreds of experiments.
6 Conclusions
The introduction and the creative use of next-generation sequencing technologies
have opened new avenues for every aspect of genetic and epigenetic research.
Perhaps the field that has benefited most from them is regulation of gene expression
at the transcriptional and post-transcriptional level. This chapter provides a brief
survey of the experimental and bioinformatic techniques currently employed for the
study of transcription factors, summarized in Fig. 3, from the identification of target
genes to the characterization of their activity, and all fundamental steps for subse-
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